Home Healthcare Pharmaceuticals Immunotherapy Drugs Market

Immunotherapy Drugs Market Size, Share & Trends Analysis Report By Type (Monoclonal Antibodies, Vaccines, Immunomodulators), By Indication (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Immunotherapy Drugs Market Size Analysis
    1. Introduction
    2. Immunotherapy Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Immunomodulators
    3. Immunotherapy Drugs Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Autoimmune and Inflammatory Diseases
      3. Infectious Diseases
  7. North America Immunotherapy Drugs Market Size Analysis
    1. Introduction
    2. Immunotherapy Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Immunomodulators
    3. Immunotherapy Drugs Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Autoimmune and Inflammatory Diseases
      3. Infectious Diseases
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
  8. Europe Immunotherapy Drugs Market Size Analysis
    1. Introduction
    2. Immunotherapy Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Immunomodulators
    3. Immunotherapy Drugs Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Autoimmune and Inflammatory Diseases
      3. Infectious Diseases
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    6. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
  9. APAC Immunotherapy Drugs Market Size Analysis
    1. Introduction
    2. Immunotherapy Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Immunomodulators
    3. Immunotherapy Drugs Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Autoimmune and Inflammatory Diseases
      3. Infectious Diseases
    4. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    7. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
  10. Middle East and Africa Immunotherapy Drugs Market Size Analysis
    1. Introduction
    2. Immunotherapy Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Immunomodulators
    3. Immunotherapy Drugs Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Autoimmune and Inflammatory Diseases
      3. Infectious Diseases
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
  11. LATAM Immunotherapy Drugs Market Size Analysis
    1. Introduction
    2. Immunotherapy Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Immunomodulators
    3. Immunotherapy Drugs Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Autoimmune and Inflammatory Diseases
      3. Infectious Diseases
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
  12. Competitive Landscape
    1. Immunotherapy Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Merck & Co., Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bristol Myers Squibb
    3. Hoffmann-La Roche Ltd.
    4. Novartis AG
    5. Gilead Sciences, Inc. (Kite Pharma)
    6. Pfizer Inc.
    7. Johnson & Johnson
    8. AstraZeneca
    9. GlaxoSmithKline (GSK)
    10. Sanofi
    11. Adaptimmune Therapeutics
    12. Allogene Therapeutics
    13. Immunocore
    14. Cellectis
    15. RyboDyn, Inc.
    16. Oncolytics Biotech
    17. Imugene Ltd
    18. Genelux Corporation
    19. Agenus Inc.
    20. Repertoire Immune Medicines
    21. Atara Biotherapeutics, Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.